This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jun;7(3):393-4.

doi: 10.1161/CIRCGENETICS.114.000687.

MicroRNA therapy for the failing heart

Almudena Martinez-Fernandez¹

Affiliations

PMID: 24951666
DOI: 10.1161/CIRCGENETICS.114.000687

Comment

MicroRNA therapy for the failing heart

Almudena Martinez-Fernandez. Circ Cardiovasc Genet. 2014 Jun.

. 2014 Jun;7(3):393-4.

doi: 10.1161/CIRCGENETICS.114.000687.

Author

Almudena Martinez-Fernandez¹

Affiliation

¹ From the Division of Cardiovascular Diseases and Center for Regenerative Medicine, Mayo Clinic, Rochester, MN. MartinezFernandez.Almudena@mayo.edu.

PMID: 24951666
DOI: 10.1161/CIRCGENETICS.114.000687

No abstract available

Keywords: SERCA2a Calcium ATPase; heart failure; miRNA; microRNAs; translational medical research.

PubMed Disclaimer

Comment on

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ; Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators. Jessup M, et al. Circulation. 2011 Jul 19;124(3):304-13. doi: 10.1161/CIRCULATIONAHA.111.022889. Epub 2011 Jun 27. Circulation. 2011. PMID: 21709064 Free PMC article. Clinical Trial.
Inhibition of miR-25 improves cardiac contractility in the failing heart.
Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, van Mil A, Park WJ, Sluijter JP, Doevendans PA, Hajjar RJ, Mercola M. Wahlquist C, et al. Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12. Nature. 2014. PMID: 24670661 Free PMC article.

Similar articles

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ; Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators. Jessup M, et al. Circulation. 2011 Jul 19;124(3):304-13. doi: 10.1161/CIRCULATIONAHA.111.022889. Epub 2011 Jun 27. Circulation. 2011. PMID: 21709064 Free PMC article. Clinical Trial.
Inhibition of miR-25 improves cardiac contractility in the failing heart.
Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, van Mil A, Park WJ, Sluijter JP, Doevendans PA, Hajjar RJ, Mercola M. Wahlquist C, et al. Nature. 2014 Apr 24;508(7497):531-5. doi: 10.1038/nature13073. Epub 2014 Mar 12. Nature. 2014. PMID: 24670661 Free PMC article.
Sarcoplasmic reticulum Ca-ATPase and heart failure 20 years later.
Eisner D, Caldwell J, Trafford A. Eisner D, et al. Circ Res. 2013 Sep 27;113(8):958-61. doi: 10.1161/CIRCRESAHA.113.302187. Circ Res. 2013. PMID: 24071456 Review. No abstract available.
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway.
Kumarswamy R, Lyon AR, Volkmann I, Mills AM, Bretthauer J, Pahuja A, Geers-Knörr C, Kraft T, Hajjar RJ, Macleod KT, Harding SE, Thum T. Kumarswamy R, et al. Eur Heart J. 2012 May;33(9):1067-75. doi: 10.1093/eurheartj/ehs043. Epub 2012 Feb 23. Eur Heart J. 2012. PMID: 22362515 Free PMC article.
Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Papolos A, Frishman WH. Papolos A, et al. Cardiol Rev. 2013 May-Jun;21(3):151-4. doi: 10.1097/CRD.0b013e3182749cdb. Cardiol Rev. 2013. PMID: 23568057 Review.

See all similar articles

Cited by

Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
Zhao G. Zhao G. J Med Genet. 2018 Nov;55(11):713-720. doi: 10.1136/jmedgenet-2018-105387. Epub 2018 Sep 3. J Med Genet. 2018. PMID: 30177556 Free PMC article. Review.
Intracoronary Sarcoplasmic Reticulum Calcium-ATPase Gene Therapy in Advanced Heart Failure Patients with reduced Ejection Fraction: A Prospective Cohort Study.
Zhang J, Hu G, Yang S. Zhang J, et al. Clinics (Sao Paulo). 2020;75:e1530. doi: 10.6061/clinics/2020/e1530. Epub 2020 Mar 13. Clinics (Sao Paulo). 2020. PMID: 32187281 Free PMC article.
Effects of propofol and etomidate anesthesia on cardiovascular miRNA expression: the different profiles?
Yao Y, Yang N, Han D, Ni C, Wu C, Guo X. Yao Y, et al. BMC Anesthesiol. 2018 Oct 24;18(1):149. doi: 10.1186/s12871-018-0610-9. BMC Anesthesiol. 2018. PMID: 30352555 Free PMC article.
Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support.
Wang T, O'Brien EC, Rogers JG, Jacoby DL, Chen ME, Testani JM, Bowles DE, Milano CA, Felker GM, Patel CB, Bonde PN, Ahmad T. Wang T, et al. ASAIO J. 2017 Sep/Oct;63(5):536-541. doi: 10.1097/MAT.0000000000000564. ASAIO J. 2017. PMID: 28319523 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information